Group GM. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. The Lancet. 2002; 359: 1011-8.
PauwelsB,KorstAE,LardonF,VermorkenJB,,2005,Combined modality therapy of gemcitabine and radiation,The Oncologist,10,34,51
PauwelsB,KorstAE,LambrechtsHA,PattynGG,de PooterCM,LardonF,,2006,The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro,Cancer Chemotherapy and Pharmacology,58,219,28
SigmondJ,HoneywellRJ,PostmaTJ,DirvenCM,De LangeSM,Van der BornK,,2009,Gemcitabine uptake in glioblastoma multiforme: potential as a radiosensitizer,Annals of Oncology,20,182,7
GertlerSZ,MacDonaldD,GoodyearM,ForsythP,StewartDJ,BelangerK,,2000,NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND. 94),Annals of Oncology,11,315,8
RiegerJ,DurkaS,StrefferJ,DichgansJ,WellerM.,,1999,Gemcitabine cytotoxicity of human malignant glioma cells: modulation by antioxidants, BCL-2 and dexamethasone,Eur J Pharmacol,365,301,8
WellerM,StrefferJ,WickW,KortmannRD,HeissE,KükerW,,2001,Preirradiation gemcitabine chemotherapy for newly diagnosed glioblastoma,Cancer,91,423,7
WickW,HermissonM,KortmannRD,KükerWM,DuffnerF,DichgansJ,,2002,Neoadjuvant gemcitabine/treosulfan chemotherapy for newly diagnosed glioblastoma,J Neuro-Oncol,59,151,5
FabiA,MirriA,FeliciA,VidiriA,PaceA,OcchipintiE,,2008,Fixed dose-rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma: a dose-finding study,J Neuro-Oncol,87,79,84
MetroG,FabiA,MirriMA,VidiriA,PaceA,CarosiM,,2010,Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme,Cancer Chemother Pharmacol,65,391,
KimMM,Camelo-PiraguaS,SchipperM,TaoY,NormolleD,JunckL,,2016,Gemcitabine Plus Radiation Therapy for HighGrade Glioma: Long-Term Results of a Phase 1 DoseEscalation Study,Int J Radiation Oncol Biol Physics,94,305,11